![Michael Koslowski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Koslowski
Director Ejecutivo en Kling Biotherapeutics BV .
Perfil
Michael Koslowski is currently the Chief Executive Officer at Kling Biotherapeutics BV since 2022.
Prior to this, he worked as the Chief Medical Officer and Head of R&D at Gammadelta Therapeutics Ltd.
Dr. Koslowski holds a doctorate degree from Universität zu Köln and an undergraduate degree from Universität des Saarlandes.
Cargos activos de Michael Koslowski
Empresas | Cargo | Inicio |
---|---|---|
Kling Biotherapeutics BV
![]() Kling Biotherapeutics BV BiotechnologyHealth Technology Kling Biotherapeutics BV is a clinical-stage biotechnology company based in the Netherlands. The Dutch company has developed a pipeline that evaluates B cells in individuals with remarkable responses to cancer and infectious diseases. Kling Biotherapeutics' proprietary B cell immortalization platform enables rapid functional screening of antibodies, leading to the identification of several antibodies targeting novel epitopes and cancer-associated antigens with unique post-translational modifications. Michael Koslowski has been the CEO of the company since 2022. | Director Ejecutivo | 12/12/2022 |
Antiguos cargos conocidos de Michael Koslowski.
Empresas | Cargo | Fin |
---|---|---|
Gammadelta Therapeutics Ltd.
![]() Gammadelta Therapeutics Ltd. BiotechnologyHealth Technology Gammadelta Therapeutics Ltd. is developing the potential of gamma delta (?d) cells to create improved immunotherapy of cancer and other serious diseases. The company was founded by Raj Mehta in 2016 and is headquartered in London, the United Kingdom. | Director Técnico/Científico/I+D | - |
Formación de Michael Koslowski.
Universität des Saarlandes | Undergraduate Degree |
Universität zu Köln | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Kling Biotherapeutics BV
![]() Kling Biotherapeutics BV BiotechnologyHealth Technology Kling Biotherapeutics BV is a clinical-stage biotechnology company based in the Netherlands. The Dutch company has developed a pipeline that evaluates B cells in individuals with remarkable responses to cancer and infectious diseases. Kling Biotherapeutics' proprietary B cell immortalization platform enables rapid functional screening of antibodies, leading to the identification of several antibodies targeting novel epitopes and cancer-associated antigens with unique post-translational modifications. Michael Koslowski has been the CEO of the company since 2022. | Health Technology |
Gammadelta Therapeutics Ltd.
![]() Gammadelta Therapeutics Ltd. BiotechnologyHealth Technology Gammadelta Therapeutics Ltd. is developing the potential of gamma delta (?d) cells to create improved immunotherapy of cancer and other serious diseases. The company was founded by Raj Mehta in 2016 and is headquartered in London, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Michael Koslowski